{"indexed":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:15:10Z","timestamp":1559441710090},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T00:00:00Z","timestamp":1447891200000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s12020-015-0803-7","type":"article-journal","created":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T09:53:42Z","timestamp":1447926822000},"page":"4-6","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":"Periostin on the road to nonalcoholic fatty liver disease","prefix":"10.1007","volume":"51","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,11,19]]},"reference":[{"key":"803_CR1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","volume":"9","author":"SA Polyzos","year":"2009","unstructured":"S.A. Polyzos, J. Kountouras, C. Zavos, Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr. Mol. Med. 9, 299\u2013314 (2009)","journal-title":"Curr. Mol. Med."},{"key":"803_CR2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.metabol.2013.10.010","volume":"63","author":"SA Polyzos","year":"2014","unstructured":"S.A. Polyzos, C.S. Mantzoros, Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease. Metabolism 63, 161\u2013167 (2014)","journal-title":"Metabolism"},{"key":"803_CR3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MCG.0b013e31824587e0","volume":"46","author":"SA Polyzos","year":"2012","unstructured":"S.A. Polyzos, J. Kountouras, C. Zavos, G. Deretzi, Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease. J. Clin. Gastroenterol. 46, 272\u2013284 (2012)","journal-title":"J. Clin. Gastroenterol."},{"key":"803_CR4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.matbio.2014.04.007","volume":"37","author":"AY Liu","year":"2014","unstructured":"A.Y. Liu, H. Zheng, G. Ouyang, Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironments. Matrix Biol. 37, 150\u2013156 (2014)","journal-title":"Matrix Biol."},{"key":"803_CR5","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1210\/jc.2013-3893","volume":"99","author":"JC Rousseau","year":"2014","unstructured":"J.C. Rousseau, E. Sornay-Rendu, C. Bertholon, R. Chapurlat, P. Garnero, Serum periostin is associated with fracture risk in postmenopausal women: a 7-year prospective analysis of the OFELY study. J. Clin. Endocrinol. Metab. 99, 2533\u20132539 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"803_CR6","first-page":"145","volume":"46","author":"AD Anastasilakis","year":"2014","unstructured":"A.D. Anastasilakis, S.A. Polyzos, P. Makras, M. Savvides, G.T. Sakellariou, A. Gkiomisi, A. Papatheodorou, E. Terpos, Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatment. Horm. Metab. Res. 46, 145\u2013149 (2014)","journal-title":"Horm. Metab. Res."},{"key":"803_CR7","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1172\/JCI74438","volume":"124","author":"Y Lu","year":"2014","unstructured":"Y. Lu, X. Liu, Y. Jiao, X. Xiong, E. Wang, X. Wang, Z. Zhang, H. Zhang, L. Pan, Y. Guan, D. Cai, G. Ning, X. Li, Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPAR\u03b1. J. Clin. Invest. 124, 3501\u20133513 (2014)","journal-title":"J. Clin. Invest."},{"key":"803_CR8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jhep.2014.10.005","volume":"62","author":"Y Li","year":"2015","unstructured":"Y. Li, S. Wu, S. Xiong, G. Ouyang, Deficiency of periostin protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis. J. Hepatol. 62, 495\u2013497 (2015)","journal-title":"J. Hepatol."},{"key":"803_CR9","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ajpath.2014.11.002","volume":"185","author":"Y Huang","year":"2015","unstructured":"Y. Huang, W. Liu, H. Xiao, A. Maitikabili, Q. Lin, T. Wu, Z. Huang, F. Liu, Q. Luo, G. Ouyang, Matricellular protein periostin contributes to hepatic inflammation and fibrosis. Am. J. Pathol. 185, 786\u2013797 (2015)","journal-title":"Am. J. Pathol."},{"key":"803_CR10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.molimm.2014.10.021","volume":"64","author":"S Amara","year":"2015","unstructured":"S. Amara, K. Lopez, B. Banan, S.K. Brown, M. Whalen, E. Myles, M.T. Ivy, T. Johnson, K.L. Schey, V. Tiriveedhi, Synergistic effect of pro-inflammatory TNF\u03b1 and IL-17 in periostin mediated collagen deposition: potential role in liver fibrosis. Mol. Immunol. 64, 26\u201335 (2015)","journal-title":"Mol. Immunol."},{"key":"803_CR11","author":"JZ Zhu","year":"2015","unstructured":"J.Z. Zhu, H.T. Zhu, Y.N. Dai, C.X. Li, Z.Y. Fang, D.J. Zhao, X.Y. Wan, Y.M. Wang, F. Wang, C.H. Yu, Y.M. Li, Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case-control study. Endocrine (2015). doi: 10.1007\/s12020-015-0735-2","journal-title":"Endocrine"},{"key":"803_CR12","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ejso.2013.06.023","volume":"39","author":"Y Lv","year":"2013","unstructured":"Y. Lv, W. Wang, W.D. Jia, Q.K. Sun, M. Huang, H.C. Zhou, H.H. Xia, W.B. Liu, H. Chen, S.N. Sun, G.L. Xu, High preoperative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy. Eur. J. Surg. Oncol. 39, 1129\u20131135 (2013)","journal-title":"Eur. J. Surg. Oncol."},{"key":"803_CR13","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/mt.2013.30","volume":"21","author":"YJ Lee","year":"2013","unstructured":"Y.J. Lee, I.S. Kim, S.A. Park, Y. Kim, J.E. Lee, D.Y. Noh, K.T. Kim, S.H. Ryu, P.G. Suh, Periostin-binding DNA aptamer inhibits breast cancer growth and metastasis. Mol. Ther. 21, 1004\u20131013 (2013)","journal-title":"Mol. Ther."},{"key":"803_CR14","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.3748\/wjg.v21.i9.2605","volume":"21","author":"GX Liu","year":"2015","unstructured":"G.X. Liu, H.Q. Xi, X.Y. Sun, B. Wei, Role of periostin and its antagonist PNDA-3 in gastric cancer metastasis. World J. Gastroenterol. 21, 2605\u20132613 (2015)","journal-title":"World J. Gastroenterol."}],"container-title":"Endocrine","original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0803-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-015-0803-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0803-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:57:14Z","timestamp":1559440634000},"score":1.0,"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,19]]},"references-count":14,"journal-issue":{"published-print":{"date-parts":[[2016,1]]},"issue":"1"},"alternative-id":["803"],"URL":"http:\/\/dx.doi.org\/10.1007\/s12020-015-0803-7","relation":{"cites":[]},"ISSN":["1355-008X","1559-0100"],"container-title-short":"Endocrine"}